New mouse model reveals lung vulnerability in post-primary tuberculosis

Tuberculosis remains a disease that most severely damages the lungs, but scientists still need better tools to understand why lung tissue is so vulnerable. In a new protocol led by Igor Kramnik, researchers describe a mouse model designed to reproduce post-primary pulmonary tuberculosis (PTB) that develops after hematogenous spread from a primary lesion. The protocol uses both the animals’ native lungs and subcutaneous lung implants to trace how infection moves through the body and where damage occurs. The work focuses on virulent Mycobacterium tuberculosis (Mtb) and follows its spread beyond the initial infection site. Rather than assuming the lung damage simply reflects where bacteria land first, this approach tests whether lung tissue itself has a particular susceptibility to severe disease. By developing a controlled system in immune hosts that models post-primary progression, the researchers provide a way to separate the effects of bacterial spread from tissue-specific responses. This is aimed at uncovering lung-centered drivers of TB pathology that are not explained solely by the route of infection.

The core of the method is a mouse model that replicates hematogenous spread of virulent Mycobacterium tuberculosis (Mtb) from a primary lesion to other body sites, including lymphoid tissue and lung tissue. Researchers follow dissemination to lymphoid tissue in many organs and then compare outcomes in the animals’ native lungs with those in subcutaneous lung implants. The protocol documents that, while virulent Mtb reaches lymphoid tissue broadly, the destructive lesions and pathology appear selectively in lung tissue. That selective lung damage occurs regardless of how the bacteria arrived, which suggests an intrinsic vulnerability of lung tissue to virulent Mtb. Using lung implants alongside native lungs allows investigators to manipulate and examine lung tissue in a controlled location while still modeling the hematogenous spread that characterizes human post-primary disease. The model is offered as a robust platform for experiments that probe lung-specific susceptibility mechanisms and for tests that require distinguishing systemic dissemination from lung-centered disease processes.

The significance of this protocol is that it gives researchers a focused and reproducible way to study why the lungs, and not other organs, bear the brunt of post-primary TB. By showing that virulent Mycobacterium tuberculosis disseminates widely to lymphoid tissue but causes selective damage in lungs, the model highlights lung-intrinsic factors that can be interrogated directly. The combination of native lung analysis and subcutaneous lung implants creates experimental flexibility: scientists can compare tissue responses in place and in an implant environment, helping to separate local tissue responses from broader immune or systemic influences. As a consequence, this platform can be used to test hypotheses about lung-specific pathways that drive TB pathology, to identify candidate targets for future therapies, and to refine our understanding of post-primary pulmonary TB progression in immune hosts. It provides a practical experimental foundation for work aimed at reducing the lung disease that causes most TB morbidity and mortality.